Followers | 789 |
Posts | 123468 |
Boards Moderated | 19 |
Alias Born | 09/05/2002 |

Tuesday, August 20, 2019 8:58:56 AM
https://finance.yahoo.com/news/1-elanco-buy-bayers-animal-101029292.html
Elanco Animal Health Incorporated (ELAN) today announced it has entered into an agreement with Bayer AG to acquire its animal health business in a transaction valued at US$7.6 billion. The transaction, which is subject to regulatory approval and other customary closing conditions, creates the second largest animal health leader [behind ZTS]…
The transaction will double Elanco’s Companion Animal business, advancing the company’s intentional portfolio mix transformation and creating a balance between its Food Animal and Companion Animal segments. Elanco expects the combined organization to continue to deliver mid-single digit revenue growth…
...Elanco will finance the transaction through both cash and equity. Bayer AG will receive $5.32 billion in cash…and $2.28 billion or approximately 68 million Elanco Animal Health common shares. This represents a 70 percent to 30 percent cash-to-equity mix.
Stock received by Bayer is subject to a 7.5 percent symmetrical collar centered on Elanco’s volume-weighted average price for the 30 trading days ended August 6, 2019 of $33.60.
The transaction is expected to close in mid-2020, subject to regulatory approvals and other customary closing conditions.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Liked By
Spread the love. Be the first to like this post!
Recent ELAN News
- Elanco Launches Varenzin™-CA1 (molidustat oral suspension) – the First-of-its-Kind Oral Treatment for Anemia in Cats with Chronic Kidney Disease • Business Wire • 09/07/2023 08:15:00 PM
- Elanco to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference • Business Wire • 09/05/2023 09:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 08:11:14 PM
- Elanco Animal Health Reports Second Quarter 2023 Results and Raises Full Year Guidance • Business Wire • 08/07/2023 10:33:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 10:30:41 AM
- Elanco Releases 2022 Environmental, Social and Governance Report, Demonstrating Sustainability Progress in Internal Operations and Customer Collaborations • Business Wire • 07/20/2023 12:00:00 PM
- Elanco Confirms Date and Conference Call for Second Quarter 2023 Financial Results Announcement • Business Wire • 07/18/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 09:27:18 PM
- Environmental Protection Agency (EPA) Completes Review of Seresto® Collar and Confirms Continued Registration; Data Affirms Safety Profile of the Product • Business Wire • 07/13/2023 09:24:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 08:15:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/06/2023 08:47:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:17:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:17:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:07:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:05:17 PM
- Elanco to Participate in Goldman Sachs 44th Annual Global Healthcare Conference • Business Wire • 06/05/2023 12:00:00 PM
- Elanco to Participate in Stifel 2023 Jaws and Paws Conference • Business Wire • 05/25/2023 12:00:00 PM
- Elanco Animal Health Reports First Quarter 2023 Results • Business Wire • 05/09/2023 10:34:00 AM
- Elanco Receives USDA License for Canine Virus Treatment • Dow Jones News • 05/02/2023 01:21:00 PM
- Elanco Announces Breakthrough Treatment for Deadly Canine Parvovirus • Business Wire • 05/02/2023 12:30:00 PM
- California Dairies, Inc. and DSM Venturing Complete Strategic Investment in Athian • PR Newswire (US) • 05/01/2023 11:35:00 PM
- Elanco Animal Health's Varenzin-CA1 Gets Conditional FDA Approval to Treat Anemia in Cats • Dow Jones News • 05/01/2023 07:47:00 PM
- Elanco Confirms Date and Conference Call for First Quarter 2023 Financial Results Announcement • Business Wire • 04/18/2023 12:00:00 PM
- Tyson Ventures invests in Athian's cloud-based carbon credit marketplace for livestock sector • PR Newswire (US) • 03/14/2023 12:00:00 PM
- Elanco to Participate in the Barclays Global Healthcare Conference • Business Wire • 03/09/2023 01:00:00 PM
Green Egg to launch $150 million bond offer for quicklime products production kiln plant Sep 22, 2023 12:11 PM
Nate's Food Co. Announces Reverse Merger and Change of Control with JP Energy Group to Drive Global Expansion • NHMD • Sep 22, 2023 9:00 AM
Trio Petroleum Corp Provides Update on Testing of the HV-1 Discovery Well • TPET • Sep 21, 2023 9:38 AM
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation • GNPX • Sep 20, 2023 8:45 AM
Caduceus Provides Update on Its Plans for The Second Half of The Fiscal Year • CSOC • Sep 20, 2023 8:26 AM
RESILIENT ENERGY INC. (RENI) PURSUING ACQUISITION TARGETS • RENI • Sep 19, 2023 10:30 AM